SynthesisFrontiers in endocrinology2023

Exploring the comparative cardiovascular death benefits of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes: a frequentist and Bayesian network meta-analysis-based scoring.

Samit Ghosal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.